Sr. Program Manager, Plasmid DNA / Cell and Gene Therapies (Client-Facing)
Danaher Corporation
Summary
The Senior Program Manager, Plasmid DNA is responsible for leading Aldevron's most strategic and complex plasmid DNA programs, with a primary focus on marketed products, commercial supply, and late-phase clinical programs progressing through process validation, Process Performance Qualification (PPQ), regulatory readiness, and commercial launch. This role serves as the senior client-facing program leader for assigned programs and integrates commercial agreements with technical and operational execution.
Job description
The Program Manager ensures alignment across scope, schedule, quality, supply continuity, financial performance, regulatory expectations, and customer commitments throughout validation, PPQ, launch preparation, recurring commercial supply, and lifecycle management. The Program Manager partners closely with Business Development, Legal, Contracts, Project Management, Manufacturing, Quality, Regulatory Affairs, Supply Chain, Technical Operations, Finance, and Executive Leadership to convert contractual commitments into executable plans, resolve complex issues, protect Aldevron's business interests, and build durable strategic client partnerships.
In this role, you will have the opportunity to:
- Lead Program and Project Execution: Lead highly complex, multi-program portfolios across strategic accounts, owning end-to-end delivery across multiple concurrent projects with significant revenue, risk, and cross-functional dependencies, ensuring alignment with timelines, budgets, and KPIs.
- Cultivate Strategic Client Relationships: Own and influence senior-level client relationships and account strategy, acting as a trusted advisor to client stakeholders, navigating escalations, and shaping program direction and long-term partnership outcomes.
- Internal Team Alignment and Development: Drive enterprise-wide alignment and decision-making, leading cross-functional teams through ambiguity, resolving competing priorities, and influencing outcomes across functions and leadership levels.
- Ensure Operational Excellence and Governance: Establish and maintain program governance structures, track project metrics, forecast capacity, and provide regular updates to senior leadership on project status, risks, and opportunities.
- Translate master service agreements, statements of work, supply and quality agreements, amendments, and change orders into executable operating requirements, and partner with Business Development, Legal, Contracts, and Finance to assess feasibility, manage scope change, support negotiations, and protect Aldevron's commercial and contractual position.
- Support Business Growth and Continuous Improvement: Responsible for overall program health, capacity strategy, business growth, including forecasting demand, identifying risks, leading proposals and renewals, and influencing account expansion and continuous improvement initiatives.
The essential requirements of the job include:
- B.S. or B.A. required. Advanced degree in scientific field strongly preferred (e.g. molecular biology, biology, biotechnology, biochemistry)
- Prefer 7+ years of experience in a client-facing role as a project, program, or account manager within the life sciences, with preference for 5+ years in a GMP-regulated CDMO environment
- Experience managing programs and contracts in a regulated biotechnology, pharmaceutical, or medical device related field required
- Working knowledge of plasmid DNA manufacturing and its use in cell and gene therapy, gene editing, mRNA, vaccines, or other genomic medicine applications; strong preference for late phase/commercial drug product experience.
- Strong analytical and problem-solving skills, with the ability to forecast risks and implement sustainable solutions.
It would be a plus if you also possess previous experience in:
- An advanced degree in a scientific, engineering, legal, project management, or business discipline, or a program or project management certification such as PMP.
- Direct program leadership for commercial or late-phase plasmid DNA programs through process characterization, technology transfer, process validation, PPQ campaigns, regulatory inspections, commercial launch, recurring supply, or post-approval lifecycle management.
- Experience managing strategic accounts, cross-site programs, long-term supply agreements, capacity reservation models, demand planning, forecast commitments, pricing protections, change-order mechanisms, termination provisions, executive governance, or commercial supply continuity.
Travel, Motor Vehicle Record & Physical/Environment Requirements:
Ability to travel up to 25% of the time, including travel to the Fargo, ND site and client locations, with overnight travel based on business and customer needs.
Requirements
- B.S. or B.A. required
- Advanced degree in scientific field strongly preferred (e.g. molecular biology, biology, biotechnology, biochemistry)
- Prefer 7+ years of experience in a client-facing role as a project, program, or account manager within the life sciences
- Preference for 5+ years in a GMP-regulated CDMO environment
- Experience managing programs and contracts in a regulated biotechnology, pharmaceutical, or medical device related field required
- Working knowledge of plasmid DNA manufacturing and its use in cell and gene therapy, gene editing, mRNA, vaccines, or other genomic medicine applications
- Strong preference for late phase/commercial drug product experience
- Strong analytical and problem-solving skills, with the ability to forecast risks and implement sustainable solutions
- Ability to travel up to 25% of the time
Benefits
- Health insurance
- Dental insurance
- Vision insurance
- 401(k)
- Paid time off
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.